BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1431141)

  • 1. The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex.
    Krumdieck R; Höök M; Rosenberg LC; Volanakis JE
    J Immunol; 1992 Dec; 149(11):3695-701. PubMed ID: 1431141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
    Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
    J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1q inhibitor (chondroitin-4-sulfate proteoglycan): structure and function.
    Ghebrehiwet B; Galanakis DK
    Behring Inst Mitt; 1993 Dec; (93):214-23. PubMed ID: 8172570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of von Willebrand factor to the small proteoglycan decorin.
    Guidetti GF; Bartolini B; Bernardi B; Tira ME; Berndt MC; Balduini C; Torti M
    FEBS Lett; 2004 Sep; 574(1-3):95-100. PubMed ID: 15358546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen.
    Schönherr E; Broszat M; Brandan E; Bruckner P; Kresse H
    Arch Biochem Biophys; 1998 Jul; 355(2):241-8. PubMed ID: 9675033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of decorin on fibroblast adhesion to fibronectin.
    Winnemöller M; Schmidt G; Kresse H
    Eur J Cell Biol; 1991 Feb; 54(1):10-7. PubMed ID: 1827765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
    Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
    J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1.
    Thielens NM; Bally IM; Ebenbichler CF; Dierich MP; Arlaud GJ
    J Immunol; 1993 Dec; 151(11):6583-92. PubMed ID: 8245486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon.
    Samiric T; Ilic MZ; Handley CJ
    Matrix Biol; 2004 May; 23(2):127-40. PubMed ID: 15246111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins.
    Groeneveld TW; Oroszlán M; Owens RT; Faber-Krol MC; Bakker AC; Arlaud GJ; McQuillan DJ; Kishore U; Daha MR; Roos A
    J Immunol; 2005 Oct; 175(7):4715-23. PubMed ID: 16177119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of a novel interaction between pulmonary surfactant protein D and decorin.
    Nadesalingam J; Bernal AL; Dodds AW; Willis AC; Mahoney DJ; Day AJ; Reid KB; Palaniyar N
    J Biol Chem; 2003 Jul; 278(28):25678-87. PubMed ID: 12730206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment.
    Winnemöller M; Schön P; Vischer P; Kresse H
    Eur J Cell Biol; 1992 Oct; 59(1):47-55. PubMed ID: 1468447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural change in decorin with skin aging.
    Nomura Y
    Connect Tissue Res; 2006; 47(5):249-55. PubMed ID: 17118746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.